CD1A and breast carcinoma: In a prior study, our group found significant decreases in immune cell populations within breast cancer non-sentinel lymph nodes (NSLNs), specifically in CD4+ T cells and CD1a+ DCs, and discovered that these changes strongly correlated with clinical outcome [15].